Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Stomach Neoplasms × Aspirin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Lynch syndrome I (site-specific colonic cancer) 1 Breast Neoplasms 1

Interventions

Oxaliplatin 10 Fluorouracil 6 Irinotecan 5 Docetaxel 5 Capecitabine 5 tislelizumab 4 S 1 (combination) 4 Paclitaxel 4 Endoscopic Mucosal Resection 4 XELOX 3 Levoleucovorin 3 Laparoscopy 3 Folfox protocol 3 sintilimab 2 apatinib 2 Proton Pump Inhibitors 2 Gastroenterostomy 2 Gastrectomy 2 vactosertib 1 titanium silicide 1 pembrolizumab 1 lenvatinib 1 durvalumab 1 anlotinib 1 Trastuzumab 1 Tranexamic Acid 1 Tomography, X-Ray Computed 1 Surgical Procedures, Operative 1 Stents 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04214990 2024-12-27

EASTERN

National Cancer Center, Korea

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡